chlorambucil has been researched along with Polychondritis, Chronic Atrophic in 1 studies
Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bochtler, T | 1 |
| Hensel, M | 1 |
| Lorenz, HM | 1 |
| Ho, AD | 1 |
| Mahlknecht, U | 1 |
1 other study available for chlorambucil and Polychondritis, Chronic Atrophic
| Article | Year |
|---|---|
Chronic lymphocytic leukaemia and concomitant relapsing polychondritis: a report on one treatment for the combined manifestation of two diseases.
Topics: Antineoplastic Agents, Alkylating; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Ear Ca | 2005 |